Ennis B W, Stumpf W E
Department of Cell Biology and Anatomy, University of North Carolina, Chapel Hill 27514.
Histochem J. 1989 Jan;21(1):52-60. doi: 10.1007/BF01002472.
Immature rats were injected subcutaneously with 0.36 micrograms of [3H]hydroxytamoxifen ([3H]TAM(OH)) or 0.24 microgram of [3H]oestradiol in oil, and 4 h later uteri were processed for thaw-mount autoradiography. The specificity of [3H]TAM(OH) localization was determined by injecting a 200-fold excess of unlabelled TAM(OH) or a 20-, 200- or 2000-fold excess of oestradiol 1 h before injection of [3H]TAM(OH). After injection of [3H]TAM(OH) or [3H]oestradiol, autoradiograms showed concentration of radioactivity in nuclei of stromal, epithelial and myometrial cells, but this labelling varied among the cell types depending upon which compound was injected. After [3H]TAM(OH) injection, the decreasing order of labelling intensity was stroma, myometrium, epithelium; after [3H]oestradiol injection the decreasing order was stroma, epithelium, myometrium. Injection of TAM(OH) before [3H]TAM(OH) eliminated nuclear labelling in all the uterine cell types. Injection of oestradiol before [3H]TAM(OH) decreased nuclear labelling and resulted in the concentration of label in the cytoplasm of luminal epithelium which was not present when [3H]TAM(OH) was injected alone. Cytoplasmic labelling increased initially as the oestradiol competition dose increased, but the increase in labelling did not continue with increasing concentrations of oestradiol. The results indicate that antioestrogen and oestrogen localize to nuclei of the same uterine cell types, but that cellular uptake differs among the tissue compartments. The results also suggest that a high concentration of antioestrogen-binding sites exist in the cytoplasm of the uterine luminal epithelium.
给未成熟大鼠皮下注射0.36微克的[3H]羟基他莫昔芬([3H]TAM(OH))或0.24微克溶于油中的[3H]雌二醇,4小时后将子宫进行冷冻切片放射自显影处理。[3H]TAM(OH)定位的特异性通过在注射[3H]TAM(OH)前1小时注射200倍过量的未标记TAM(OH)或20、200或2000倍过量的雌二醇来确定。注射[3H]TAM(OH)或[3H]雌二醇后,放射自显影片显示放射性集中在基质、上皮和肌层细胞的细胞核中,但这种标记在不同细胞类型中有所不同,具体取决于注射的是哪种化合物。注射[3H]TAM(OH)后,标记强度的递减顺序为基质、肌层、上皮;注射[3H]雌二醇后,递减顺序为基质、上皮、肌层。在[3H]TAM(OH)之前注射TAM(OH)可消除所有子宫细胞类型中的细胞核标记。在[3H]TAM(OH)之前注射雌二醇可减少细胞核标记,并导致标记集中在腔上皮细胞的细胞质中,而单独注射[3H]TAM(OH)时则不存在这种情况。随着雌二醇竞争剂量的增加,细胞质标记最初增加,但随着雌二醇浓度的进一步增加,标记的增加并未持续。结果表明,抗雌激素和雌激素定位于相同子宫细胞类型的细胞核中,但细胞摄取在不同组织隔室中有所不同。结果还表明,子宫腔上皮细胞的细胞质中存在高浓度的抗雌激素结合位点。